Summary: Tocilizumab is a novel monoclonal antibody that competitively inhibits the binding of interleukin-6 (IL-6) to its receptor (IL-6R). Inhibiting the entire receptor complex prevents IL-6 ...

In mice, dampening the activity of area postrema neurons diminished cancer-induced muscle and fat loss and increased lifespan ...